GENEVA, March 9 -- JIANGSU KANION PHARMACEUTICAL CO., LTD. (Jiangning Industrial CityEconomic And TechnologicalDevelopment ZoneLianyungang, Jiangsu 222047), 江苏康缘药业股份有限公司 (中国江苏省连云港市经济技术开发区江宁工业城) filed a patent application (PCT/CN2025/116716) for "ANTIBODY TARGETING IGF-1R AND USE THEREOF" on Aug 25, 2025. With publication no. WO/2026/046112, the details related to the patent application was published on Mar 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) ...